Skip to main content
Livermore
Livermore
ZHEN

First Light Asset Management, LLC

SEC CIK
0001600004
Latest filing
Aug 14, 2026

Holdings in Q4 2024

Holdings as of Dec 31, 2024, filed Feb 14, 2025. Long positions only; changes compare share counts with Q3 2024.

Institution overview
Positions
36
−2 vs. Q3 2024
Portfolio value
$1.05B
−$156.8M (−13.0%) vs. Q3 2024
Filed
Feb 14, 2025
SEC
Holdings of First Light Asset Management, LLC in Q4 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
FNAParagon 28, Inc.COM10,580,467$109.3M10.5%+425,824+4.2%AddedHistory
CNTACentessa Pharmaceuticals plcSPONSORED ADS5,805,184$97.2M9.3%−134,948−2.3%ReducedHistory
AXGNAxogen, Inc.COM4,506,795$74.3M7.1%+416,499+10.2%AddedHistory
ATRCAtriCure, Inc.COM1,969,221$60.2M5.8%+103,685+5.6%AddedHistory
TWSTTwist Bioscience CorpCOM1,226,255$57.0M5.5%+1,226,255NewHistory
VERAVera Therapeutics, Inc.CL A1,261,246$53.3M5.1%+556,012+78.8%AddedHistory
NEONeogenomics IncCOM NEW3,167,585$52.2M5.0%+91,030+3.0%AddedHistory
XENEXenon Pharmaceuticals Inc.COM1,160,580$45.5M4.4%−21,082−1.8%ReducedHistory
CRNXCrinetics Pharmaceuticals, Inc.COM885,453$45.3M4.3%−58,158−6.2%ReducedHistory
IRTCiRhythm Holdings, Inc.COM430,500$38.8M3.7%+430,500NewHistory
HCATHealth Catalyst, Inc.COM5,241,121$37.1M3.5%+944,631+22.0%AddedHistory
PHLTPerformant Healthcare IncCOM11,346,649$34.3M3.3%+136,249+1.2%AddedHistory
INSMINSMED IncCOM PAR $.01470,192$32.5M3.1%−218,718−31.7%ReducedHistory
MDXGMimedx Group, Inc.COM3,343,861$32.2M3.1%+3,343,861NewHistory
RAREUltragenyx Pharmaceutical Inc.COM763,607$32.1M3.1%+8,505+1.1%AddedHistory
KRMDKORU Medical Systems, Inc.COM5,915,434$22.8M2.2%+316,509+5.7%AddedHistory
PLRXPliant Therapeutics, Inc.COM1,681,110$22.1M2.1%−894,436−34.7%ReducedHistory
EWTXEdgewise Therapeutics, Inc.COM780,639$20.8M2.0%+780,639NewHistory
JANXJanux Therapeutics, Inc.COM313,782$16.8M1.6%+313,782NewHistory
SIBNSI-BONE, Inc.COM1,136,982$15.9M1.5%−389,233−25.5%ReducedHistory
KYMRKymera Therapeutics, Inc.COM383,310$15.4M1.5%−23,038−5.7%ReducedHistory
NTRANatera, Inc.COM93,088$14.7M1.4%−91,851−49.7%ReducedHistory
BFLYButterfly Network, Inc.COM CL A3,994,620$12.5M1.2%+3,994,620NewHistory
RGENRepligen CorpCOM82,455$11.9M1.1%−83,418−50.3%ReducedHistory
ANABAnaptysbio, IncCOM868,882$11.5M1.1%−79,249−8.4%ReducedHistory
GPCRStructure Therapeutics Inc.SPONSORED ADS398,855$10.8M1.0%−107,367−21.2%ReducedHistory
TNDMTandem Diabetes Care IncCOM NEW292,117$10.5M1.0%−733,190−71.5%ReducedHistory
DYNDyne Therapeutics, Inc.COM420,431$9.91M0.9%−836,854−66.6%ReducedHistory
ELDNEledon Pharmaceuticals, Inc.COM2,328,768$9.59M0.9%+2,328,768NewHistory
GHGuardant Health, Inc.COM309,389$9.45M0.9%−339,604−52.3%ReducedHistory
PODDInsulet CorpStock33,821$8.83M0.8%−125,261−78.7%ReducedHistory
TMDXTransMedics Group, Inc.COM139,757$8.71M0.8%−125,977−47.4%ReducedHistory
OSCROscar Health, Inc.CL A546,822$7.35M0.7%−1,219,070−69.0%ReducedHistory
SENSSenseonics Holdings, Inc.COM6,431,799$3.37M0.3%+6,431,799NewHistory
EVHEvolent Health, Inc.CL A53,620$603.2K0.1%−2,244,641−97.7%ReducedHistory
iShares Russell 2000 Growth ETF464287648ETF1,208$347.7K<0.1%+1,208New–

Sold out since Q3 2024 (11)

Positions held at the end of Q3 2024 that are gone from this filing.

Positions of First Light Asset Management, LLC sold out since Q3 2024
SecurityClassShares in Q3 2024Value in Q3 2024% of portfolio in Q3 2024History
CDMOAvid Bioservices, Inc.COM2,771,853$31.5M2.6%History
BCYCBicycle Therapeutics PLCSPONSORED ADS967,006$21.9M1.8%History
OPRXOptimizeRx CorpCOM NEW1,811,611$14.0M1.2%History
RLAYRelay Therapeutics, Inc.COM1,542,406$10.9M0.9%History
AVTRAvantor, Inc.COM359,150$9.29M0.8%History
MOHMolina Healthcare, Inc.COM26,528$9.14M0.8%History
ASNDAscendis Pharma A/SSPONSORED ADR51,723$7.72M0.6%History
NARIInari Medical, Inc.Stock174,590$7.20M0.6%History
EXASExact Sciences CorpCOM69,447$4.73M0.4%History
ATECAlphatec Holdings, Inc.COM NEW138,006$767.3K0.1%History
SONXSonendo, Inc.COM5,886,207$253.7K<0.1%History